Press release
Molecular Diagnostics Market to Reach USD 20.2 Billion by 2029, Driven by Technological Advancements and Growing Demand for Precision Medicine
Mordor Intelligence has published a new report on the Molecular Diagnostics Market, offering a comprehensive analysis of trends, growth drivers, and future projections.The global molecular diagnostics market is poised for remarkable growth, with its size projected to rise from USD 13.01 billion in 2024 to USD 20.22 billion by 2029, reflecting a compound annual growth rate (CAGR) of 9.22%. The expansion is fueled by advancements in diagnostic technologies, the increasing prevalence of infectious diseases and cancers, and a growing focus on personalized medicine. Molecular diagnostics has emerged as a cornerstone of modern healthcare, offering unparalleled precision and efficiency in disease detection and management.
Report Overview: https://www.mordorintelligence.com/industry-reports/molecular-diagnostics-market
Key Trends
1. Increasing Prevalence of Infectious Diseases
The rising incidence of infectious diseases has amplified the demand for molecular diagnostics.
COVID-19 and Beyond: During the COVID-19 pandemic, molecular diagnostics played a critical role in rapid virus detection, setting new benchmarks for testing precision and speed.
Emerging Pathogens: Diseases like MERS, Zika, and influenza continue to highlight the importance of advanced diagnostic tools capable of detecting pathogens quickly and accurately.
2. Growing Adoption of Point-of-Care Diagnostics
Point-of-care (POC) diagnostics are transforming healthcare delivery by enabling rapid disease detection at the patient's bedside or in primary care settings.
Efficiency and Precision: POC devices provide faster results compared to traditional lab methods, enhancing patient outcomes in chronic disease management and acute care scenarios.
Widespread Applications: From tuberculosis and influenza to diabetes management through glycated hemoglobin (HbA1c) tests, POC diagnostics are seeing widespread adoption.
3. Technological Innovations in Molecular Diagnostics
Advancements in molecular technologies, such as PCR, next-generation sequencing (NGS), and CRISPR-based tools, are revolutionizing diagnostics.
PCR Dominance: Polymerase Chain Reaction (PCR) remains a cornerstone technology, commanding 53% of the global market share due to its unmatched sensitivity and versatility.
Pharmacogenomics and Precision Medicine: The growing emphasis on personalized medicine has propelled the adoption of molecular diagnostics in tailoring treatments to individual genetic profiles.
4. Rising Investment in R&D
Governments and private entities are investing significantly in R&D for molecular diagnostics, fostering the development of innovative solutions to meet evolving healthcare demands.
Market Segmentation
The molecular diagnostics market is segmented by Technology, Application, Product, End User, and Geography:
By Technology:
PCR: A dominant segment owing to its high sensitivity in detecting pathogens and genetic mutations.
NGS: Rapidly growing due to its applications in genetic screening and oncology.
In Situ Hybridization: Used extensively in cancer diagnostics and research.
Chips and Microarrays: Facilitates large-scale genetic analysis.
Mass Spectrometry: Integral to proteomics and metabolomics studies.
By Application:
Infectious Diseases: The largest segment due to its critical role in pathogen detection.
Oncology: Growing demand for cancer diagnostics and biomarker identification.
Genetic Disease Screening: Addressing hereditary conditions through advanced testing.
Microbiology: Enhancing the understanding of microbial pathogens.
Blood Screening: Essential for transfusion safety and disease detection.
By Product:
Instruments: Includes high-tech diagnostic machines.
Reagents: Consumables essential for molecular tests.
Other Products: Accessories and software solutions supporting diagnostics.
By End User:
Hospitals: Major consumers due to the need for immediate and precise diagnostics.
Laboratories: Centralized facilities performing high volumes of tests.
Other End Users: Includes research institutions and outpatient clinics.
By Geography:
North America: Leading market due to advanced healthcare infrastructure and high adoption of new technologies.
Europe: Strong focus on precision medicine and government support for diagnostics.
Asia-Pacific: Fastest-growing market, driven by increasing healthcare investments and population base.
Middle East & Africa: Emerging market focusing on improving diagnostic access.
South America: Expanding market with rising awareness and adoption of molecular diagnostics.
Get a Customized Report Tailored to Your Requirements. - https://www.mordorintelligence.com/market-analysis/molecular-diagnostic-devices
Key Players
Major players driving the molecular diagnostics market include Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Qiagen, and Hologic, Inc. These companies lead through innovation, strategic collaborations, and a strong focus on research and development.
Roche Diagnostics: A global leader in molecular testing with a comprehensive portfolio of PCR and NGS technologies.
Abbott Laboratories: Renowned for POC diagnostic solutions and advanced molecular platforms.
Thermo Fisher Scientific: Known for its robust offerings in genetic testing and sequencing technologies.
Qiagen: Specializes in sample preparation and molecular analysis tools.
Hologic, Inc.: Focuses on women's health and infectious disease diagnostics.
These companies are setting industry standards by introducing cutting-edge technologies and expanding their global footprints to address diverse healthcare needs.
Conclusion
The molecular diagnostics market is on a robust growth trajectory, driven by technological innovations, rising prevalence of infectious diseases, and the growing adoption of personalized medicine. As healthcare systems increasingly rely on precise and efficient diagnostic tools, the market is set to play a pivotal role in shaping the future of disease management and treatment. With continued investments in R&D and advancements in diagnostic technologies, molecular diagnostics will remain a cornerstone of modern healthcare, enhancing patient outcomes and advancing global health standards.
Industry Related Reports
PCR Molecular Diagnostics Market: The PCR Molecular Diagnostics Market Report is segmented by Product Type (Instruments, Reagents and Consumables, and Software), Application (Infectious Disease Testing, Oncology Testing, and Other Applications), End Users (Hospitals, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).
To know more visit this link: https://www.mordorintelligence.com/industry-reports/pcr-molecular-diagnostics
POC Molecular Diagnostics Market: The POC Molecular Diagnostics Market is segmented by Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Other Applications), Technology (PCR, Genetic Sequencing, Hybridization, and Microarray), End User (Hospitals, Homecare, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).
To know more visit this link: https://www.mordorintelligence.com/industry-reports/point-of-care-molecular-diagnostics-market
Europe Molecular Diagnostics Market: The Europe Molecular Diagnostics Market Report is segmented by Technology (In Situ Hybridization, Chips and Microarrays, Mass Spectrometry (MS), Sequencing, PCR, and Other Technologies), Application (Infectious Diseases, Oncology, Pharmacogenomics, Microbiology, Genetic Disease Testing, and Other Applications), Product (Instruments, Reagents, and Other Products), End User (Hospitals, Laboratories, and Other End Users), and Geography (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe)
To know more visit this link: https://www.mordorintelligence.com/industry-reports/europe-molecular-diagnostics-market
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Molecular Diagnostics Market to Reach USD 20.2 Billion by 2029, Driven by Technological Advancements and Growing Demand for Precision Medicine here
News-ID: 3750853 • Views: …
More Releases from Mordor Intelligence

Dairy Alternatives Market to Reach USD 59.8 Billion by 2030, Driven by Rising Pl …
The Dairy Alternatives Market is projected to be valued at USD 35.53 billion in 2025 and reach USD 59.8 billion by 2030, growing at a CAGR of 10.97% during the forecast period (2025-2030).
The global dairy alternatives market is experiencing remarkable growth, driven by increasing consumer preference for plant-based and lactose-free products. The shift towards veganism, concerns over lactose intolerance, and the growing awareness of the environmental impact of dairy farming…

Wind Turbine Market Projected to Reach 1.39 Thousand Gigawatts by 2030 Amidst Te …
Mordor Intelligence has published a new report on the Wind Turbine Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
The Wind Turbine Market is projected to grow from 0.21 thousand gigawatts in 2025 to 1.39 thousand gigawatts by 2030, with a compound annual growth rate (CAGR) of 45.66% during the forecast period (2025-2030). The growth of the wind turbine market is driven by the rising demand…

Saudi Arabia Renewable Energy Market to Reach 29.27 GW by 2030, Driven by Ambiti …
Mordor Intelligence has published a new report on the Saudi Arabia Renewable Energy Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
The Saudi Arabia Renewable Energy Market is projected to grow from 10.27 gigawatts in 2025 to 29.27 gigawatts by 2030, reflecting a compound annual growth rate (CAGR) of 23.3% during the forecast period (2025-2030).
Saudi Arabia's renewable energy sector is experiencing a significant transformation, fueled by…

Aluminum Market Projected to Surpass USD 150 Billion by 2030 Amidst Sustainabili …
Mordor Intelligence has published a new report on the Aluminum Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
The Aluminum Market is projected to grow at a CAGR of over 3.5% during the forecast period and expected to exceed USD 150 billion by 2030.
The aluminum industry is undergoing a major transformation, driven by sustainability initiatives and technological advancements. Leading manufacturers are placing greater emphasis on producing low-carbon…
More Releases for Diagnostic
Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects.
Tenet Diagnostics got its NABL certification in the fastest time and is…
Global Tissue Diagnostic Market 2020 Business Strategies – Roche Diagnostic, A …
The Zion Market Research added a new report “Tissue Diagnostic Market by Product Type (Consumables and Instruments), by Technology (Immunohistochemistry (IHC), in Situ Hybridization (ISH), Digital Pathology and Workflow Management, and Special Staining), by Diseases (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Others), and by End-users (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017…
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends…
POC Cardiovascular Diagnostic Market Report 2018: Segmentation by Product (Diagn …
Global POC Cardiovascular Diagnostic market research report provides company profile for F. Hoffmann-La Roche, Siemens, Abbott, Biomerieux, Danaher and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on…
Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users
Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening cervical infection, which in turn propels the demand for development of DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV…
Diagnostic Imaging Services Market Trending Technologies and Company Overview 20 …
Diagnostic Imaging Services market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the…